S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SRRK Scholar Rock Holdings Corporation

37.02

0.00 (0.00%)

27 Feb 2025 - Closed

Delayed by 15 minutes

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Scholar Rock (NASDAQ:SRRK)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more Scholar Rock Charts.

Scholar Rock (NASDAQ:SRRK)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more Scholar Rock Charts.

Scholar Rock Holdings Corporation News

Scholar Rock to Participate in Upcoming Investor Conferences
Wednesday 26 February 2025 (1 day ago) • Business Wire

Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference
Saturday 22 February 2025 (6 days ago) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Friday 21 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 21 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 21 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Friday 21 February 2025 (6 days ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 20 February 2025 (1 week ago) • Edgar (US Regulatory)

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Saturday 15 February 2025 (2 weeks ago) • Business Wire

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 13 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Scholar Rock to Host Conference Call to Discuss Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Update on February 27, 2025
Tuesday 11 February 2025 (2 weeks ago) • Business Wire

Form 8-K - Current report
Thursday 30 January 2025 (4 weeks ago) • Edgar (US Regulatory)

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)
Thursday 30 January 2025 (4 weeks ago) • Business Wire

More Scholar Rock Holdings Corporation News Articles

Cameo Industries

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions